These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34836270)

  • 1. Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria.
    Scala I; Concolino D; Nastasi A; Esposito G; Crisci D; Sestito S; Ferraro S; Albano L; Ruoppolo M; Parenti G; Strisciuglio P
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
    Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
    Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria.
    Porta F; Giorda S; Ponzone A; Spada M
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1519-1523. PubMed ID: 33581706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
    Yano S; Moseley K; Fu X; Azen C
    PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult
    van Vliet D; van der Goot E; van Ginkel WG; van Faassen MHJR; de Blaauw P; Kema IP; Martinez A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31546852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large neutral amino acids in daily practice.
    Ahring KK
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S187-90. PubMed ID: 20300852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.
    van Spronsen FJ; Smit PG; Koch R
    J Inherit Metab Dis; 2001 Feb; 24(1):1-4. PubMed ID: 11286377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids.
    Concolino D; Mascaro I; Moricca MT; Bonapace G; Matalon K; Trapasso J; Radhakrishnan G; Ferrara C; Matalon R; Strisciuglio P
    Eur J Clin Nutr; 2017 Jan; 71(1):51-55. PubMed ID: 27623981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
    Matalon R; Michals-Matalon K; Bhatia G; Burlina AB; Burlina AP; Braga C; Fiori L; Giovannini M; Grechanina E; Novikov P; Grady J; Tyring SK; Guttler F
    J Inherit Metab Dis; 2007 Apr; 30(2):153-8. PubMed ID: 17334706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
    Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

  • 20. Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.
    Yano S; Moseley K; Azen C
    J Pediatr; 2014 Jul; 165(1):184-189.e1. PubMed ID: 24857519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.